← All stocks

LIGAND PHARMACEUTICALS INC

LGND Net selling
CIK 0000886163 #1265 in the set updated 17 Sep 2026
Bought (120 mo)
$3.76M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$195.47M
$2.43M on a plan · $129.99M straight out of an exercise
Sold at will
$63.05M
80 of 261 sales
Net
−$191.71M
−$59.29M against sales at will

By person

17 insiders · 356 transactions
78.4×

Todd C. Davis holds 78.4 times base salary in stock. $56.86M of shares against $724.50K in salary for 2025.

Salary from the company's own proxy. The shares are what Todd C. Davis last reported holding, valued at $285.00, the price Common Stock was last bought or sold at on the open market here, on 10 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
HIGGINS JOHN L
Director
$854.26K (4)
$55.17M (25) scheduled
−$54.31M
417,695
2.10%
$119.04M
+198.8%
Aryeh Jason
Director
$744.81K (12)
$25.42M (20)
−$24.68M
154,174
0.7734%
$43.94M
−49.6%
FOEHR MATTHEW W
Former Executive Officer
$206.91K (1)
$23.77M (14) scheduled
−$23.56M
162,187
0.8136%
$46.22M
+95.3%
Espinoza Octavio
Chief Financial Officer
$156.09K (2)
$15.27M (25) scheduled
−$15.12M
27,696
0.1389%
$7.89M
+124.8%
Berkman Charles S
Former Executive Officer
$12.57M (5)
−$12.57M
23,825
0.1195%
$6.79M
−37.2%
Korenberg Matthew E
President & COO
$43.09K (1)
$12.57M (15) scheduled
−$12.53M
50,777
0.2547%
$14.47M
+233.4%
Reardon Andrew
CLO & Secretary
$10.20M (61) scheduled
−$10.20M
36,514
0.1832%
$10.41M
+203.5%
Patel Sunil
Former Director
$178.50K (2)
$10.15M (1) scheduled
−$9.97M
28,820
0.1446%
$8.21M
−25.4%
Sabba Stephen L
Director
$6.76M (11) scheduled
−$6.76M
33,629
0.1687%
$9.58M
+20.3%
LAMATTINA JOHN L
Director
$6.25M (13) scheduled
−$6.25M
26,969
0.1353%
$7.69M
+28.4%
KOZARICH JOHN W
Director
$5.34M (58)
−$5.34M
42,622
0.2138%
$12.15M
+6.3%
Davis Todd C
Chief Executive Officer
$1.58M (6)
$6.49M (6)
−$4.92M
199,513
1.00%
$56.86M
+250.5%
Haas Jason
Director
$3.74M (3) scheduled
−$3.74M
3,981
0.0200%
$1.13M
+217.7%
Gray Nancy Ryan
Director
$1.43M (3) scheduled
−$1.43M
8,930
0.0448%
$2.55M
+1,142%
Zimmermann Martine
Director
$342.00K (1)
−$342.00K
3,897
0.0195%
$1.11M
Boyce Sarah
Former Director
2,892
0.0145%
$824.22K
Cochran Jennifer R.
Former Director
1,161
0.0058%
$330.89K
Insider
Date
Role
Action
Shares
Price
Amount
Espinoza Octavio
27 May 2026
Chief Financial Officer
Exercised, kept
972
$52.84
$51.36K
Espinoza Octavio
27 May 2026
Chief Financial Officer
Exercised, kept
764
$63.62
$48.61K
Espinoza Octavio
16 Dec 2025
Chief Financial Officer
Exercised, kept
181
$103.42
$18.72K
Espinoza Octavio
16 Dec 2025
Chief Financial Officer
Exercised, kept
652
$92.65
$60.41K
Espinoza Octavio
16 Dec 2025
Chief Financial Officer
Exercised, kept
285
$63.62
$18.13K
Espinoza Octavio
16 Dec 2025
Chief Financial Officer
Exercised, kept
69
$57.22
$3.95K
Espinoza Octavio
16 Dec 2025
Chief Financial Officer
Exercised, kept
1,194
$52.84
$63.09K
Aryeh Jason
8 Dec 2025
Director
Exercised, kept
2,034
$69.51
$141.38K
Sabba Stephen L
1 Apr 2025
Director
Exercised, kept
2,406
$52.30
$125.83K
KOZARICH JOHN W
17 Jan 2025
Director
Exercised, kept
2,406
$52.30
$125.83K
Espinoza Octavio
17 Sep 2024
Chief Financial Officer
Exercised, kept
69
$57.22
$3.95K
Espinoza Octavio
17 Sep 2024
Chief Financial Officer
Exercised, kept
1,417
$80.72
$114.38K
Korenberg Matthew E
16 Sep 2024
President & COO
Exercised, kept
3,340
$60.94
$203.54K
Korenberg Matthew E
16 Sep 2024
President & COO
Exercised, kept
671
$49.99
$33.54K
Korenberg Matthew E
16 Sep 2024
President & COO
Exercised, kept
849
$58.49
$49.66K
Korenberg Matthew E
16 Sep 2024
President & COO
Exercised, kept
914
$55.75
$50.96K
Espinoza Octavio
28 Aug 2024
Chief Financial Officer
Exercised, kept
546
$70.04
$38.24K
Espinoza Octavio
28 Aug 2024
Chief Financial Officer
Exercised, kept
207
$57.22
$11.84K
Aryeh Jason
30 Apr 2024
Director
Exercised, kept
2,406
$52.30
$125.83K
KOZARICH JOHN W
24 Apr 2024
Director
Exercised, kept
2,893
$39.35
$113.84K
Davis Todd C
25 Mar 2024
Chief Executive Officer
Exercised, kept
3,556
$66.19
$235.37K
Davis Todd C
25 Mar 2024
Chief Executive Officer
Exercised, kept
2,156
$68.51
$147.71K
Davis Todd C
25 Mar 2024
Chief Executive Officer
Exercised, kept
2,855
$67.24
$191.97K
Davis Todd C
25 Mar 2024
Chief Executive Officer
Exercised, kept
7,448
$46.20
$344.10K
Aryeh Jason
5 Mar 2024
Director
Exercised, kept
2,893
$39.35
$113.84K
HIGGINS JOHN L
12 Dec 2022
Director
Exercised, kept
20,000
$12.78
$255.60K
HIGGINS JOHN L
18 Nov 2022
Chief Executive Officer
Exercised, kept
10,000
$12.78
$127.80K
HIGGINS JOHN L
9 May 2022
Chief Executive Officer
Exercised, kept
8,000
$21.92
$175.36K
FOEHR MATTHEW W
28 May 2021
President and COO
Exercised, kept
1,755
$56.26
$98.74K
KOZARICH JOHN W
11 May 2021
Director
Exercised, kept
4,835
$10.12
$48.93K
KOZARICH JOHN W
22 Feb 2021
Director
Exercised, kept
2,500
$10.12
$25.30K
Davis Todd C
11 Feb 2021
Director
Exercised, kept
2,474
$195.91
$484.68K
Davis Todd C
27 Jan 2021
Director
Exercised, kept
2,456
$113.50
$278.76K
HIGGINS JOHN L
8 Dec 2020
Chief Executive Officer
Exercised, kept
14,657
$10.05
$147.30K
HIGGINS JOHN L
9 Nov 2020
Chief Executive Officer
Exercised, kept
20,000
$10.05
$201.00K
HIGGINS JOHN L
7 Jul 2020
Chief Executive Officer
Exercised, kept
1,373
$74.42
$102.18K
HIGGINS JOHN L
7 Jul 2020
Chief Executive Officer
Exercised, kept
1,777
$56.26
$99.97K
HIGGINS JOHN L
7 Jul 2020
Chief Executive Officer
Exercised, kept
1,165
$85.79
$99.95K
FOEHR MATTHEW W
13 Mar 2020
President and COO
Exercised, kept
2,000
$21.92
$43.84K
FOEHR MATTHEW W
13 Feb 2020
President and COO
Exercised, kept
496
$21.92
$10.87K
HIGGINS JOHN L
13 Feb 2020
Chief Executive Officer
Exercised, kept
48,125
$9.96
$479.33K
FOEHR MATTHEW W
12 Nov 2019
President and COO
Exercised, kept
1,001
$21.92
$21.94K
FOEHR MATTHEW W
5 Sep 2019
President and COO
Exercised, kept
1,005
$21.92
$22.03K
Showing 250 of 356 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 416
Amendments (4/A) skipped 11
Filings about a different issuer 6
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 51
Sales straight out of an exercise 130
Sales at will 80
Transactions with no price 0
Shares from compensation/vesting 2,225,995
Sales filed before the plan box existed 46
History held since 6 Sep 2016